Mitsubishi Gas Company has founded, in April 2014, a subsidiary, MGC Pharma, which will start contract manufacturing of antibodies and biosimilars within 5 years using cell culture and single-use fermentation.
MGC news release, website
Mitsubishi Gas subsidiary starts contract manufacturing of antibody drugs and biosimilars